Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paraskevi Heldin

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
International Journal of Cancer|January 25, 2002
Testicular hyaluronidase induces tubular structures of endothelial cells grown in three-dimensional collagen gel through a CD44-mediated mechanismMehdi Rahmanian, Paraskevi Heldin
Biochimica Et Biophysica Acta|February 25, 2014
TGFβ and matrix-regulated epithelial to mesenchymal transitionAristidis Moustakas, Paraskevi Heldin
Plos One|March 12, 2014
Knock-down of CD44 regulates endothelial cell differentiation via NFκB-mediated chemokine productionBerit Olofsson, Helena Porsch, Paraskevi Heldin
The Journal of Biological Chemistry|October 22, 2011
Hyaluronan synthase 2 (HAS2) promotes breast cancer cell invasion by suppression of tissue metalloproteinase inhibitor 1 (TIMP-1)Berit Bernert, Helena Porsch, Paraskevi Heldin
Methods in Molecular Biology (Clifton, N.J.)|January 20, 2023
In Vitro Investigation of Hyaluronan/CD44 NetworkTheodore Karalis, Paraskevi Heldin, Spyros S Skandalis
Seminars in Cancer Biology|July 6, 2019
Intracellular hyaluronan: Importance for cellular functionsSpyros S Skandalis, Theodoros Karalis, Paraskevi Heldin
The Journal of Biological Chemistry|July 1, 2006
Inhibition of platelet-derived growth factor-BB-induced receptor activation and fibroblast migration by hyaluronan activation of CD44Lingli Li, Carl-Henrik Heldin, Paraskevi Heldin
International Journal of Cancer|October 25, 2002
Expression of hyaluronan synthase 2 or hyaluronidase 1 differentially affect the growth rate of transplantable colon carcinoma cell tumorsAnnica Jacobson, Mehdi Rahmanian, Kristofer Rubin, et al.
Advances in Cancer Research|August 2, 2014
HAS2 and CD44 in breast tumorigenesisParaskevi Heldin, Kaustuv Basu, Inna Kozlova, et al.
International Journal of Cancer|February 23, 2007
Silencing of hyaluronan synthase 2 suppresses the malignant phenotype of invasive breast cancer cellsYuejuan Li, Lingli Li, Tracey J Brown, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
International Journal of Cancer|January 25, 2002
Testicular hyaluronidase induces tubular structures of endothelial cells grown in three-dimensional collagen gel through a CD44-mediated mechanismMehdi Rahmanian, Paraskevi Heldin
Biochimica Et Biophysica Acta|February 25, 2014
TGFβ and matrix-regulated epithelial to mesenchymal transitionAristidis Moustakas, Paraskevi Heldin
Plos One|March 12, 2014
Knock-down of CD44 regulates endothelial cell differentiation via NFκB-mediated chemokine productionBerit Olofsson, Helena Porsch, Paraskevi Heldin
The Journal of Biological Chemistry|October 22, 2011
Hyaluronan synthase 2 (HAS2) promotes breast cancer cell invasion by suppression of tissue metalloproteinase inhibitor 1 (TIMP-1)Berit Bernert, Helena Porsch, Paraskevi Heldin
Methods in Molecular Biology (Clifton, N.J.)|January 20, 2023
In Vitro Investigation of Hyaluronan/CD44 NetworkTheodore Karalis, Paraskevi Heldin, Spyros S Skandalis
Seminars in Cancer Biology|July 6, 2019
Intracellular hyaluronan: Importance for cellular functionsSpyros S Skandalis, Theodoros Karalis, Paraskevi Heldin
The Journal of Biological Chemistry|July 1, 2006
Inhibition of platelet-derived growth factor-BB-induced receptor activation and fibroblast migration by hyaluronan activation of CD44Lingli Li, Carl-Henrik Heldin, Paraskevi Heldin
International Journal of Cancer|October 25, 2002
Expression of hyaluronan synthase 2 or hyaluronidase 1 differentially affect the growth rate of transplantable colon carcinoma cell tumorsAnnica Jacobson, Mehdi Rahmanian, Kristofer Rubin, et al.
Advances in Cancer Research|August 2, 2014
HAS2 and CD44 in breast tumorigenesisParaskevi Heldin, Kaustuv Basu, Inna Kozlova, et al.
International Journal of Cancer|February 23, 2007
Silencing of hyaluronan synthase 2 suppresses the malignant phenotype of invasive breast cancer cellsYuejuan Li, Lingli Li, Tracey J Brown, et al.
Pageof 5